Follow the 迪哲医药 stock price and the full management transaction log of the company, a listed issuer based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 迪哲医药 has logged 18 insider filings. Market capitalisation: €25.9bn. The latest transaction was reported on 21 August 2025 (Purchase). Among the most active insiders: XIAOLIN ZHANG. Every trade is accessible without an account.
18
Insider Decl.
n/a
Thresholds
€5m
3 ops.
Buy Volume
€13m
15 ops.
Sell Volume
21Σ signal
Buys €5m€13m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,620 of 29,064 companies
29.8
score / 100
Value
27
Quality
33
FCF yld-2.9%
Earn yld-3.0%
EV/EBITDA·
ROE-107%
Gross mgn96%
Net mgn-95%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.